Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock - Currency: USD

124.04  -0.85 (-0.68%)

Premarket: 124.04 0 (0%)

Fundamental Rating

7

DORM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. DORM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DORM has a correct valuation and a medium growth rate. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
DORM had positive earnings in each of the past 5 years.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

DORM has a better Return On Assets (8.84%) than 92.50% of its industry peers.
With an excellent Return On Equity value of 16.05%, DORM belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.64%, DORM belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DORM is in line with the industry average of 9.12%.
The 3 year average ROIC (9.34%) for DORM is below the current ROIC(12.64%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.84%
ROE 16.05%
ROIC 12.64%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM's Profit Margin of 10.48% is amongst the best of the industry. DORM outperforms 97.50% of its industry peers.
In the last couple of years the Profit Margin of DORM has grown nicely.
DORM's Operating Margin of 15.55% is amongst the best of the industry. DORM outperforms 98.75% of its industry peers.
DORM's Operating Margin has improved in the last couple of years.
DORM has a better Gross Margin (40.65%) than 93.75% of its industry peers.
In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 15.55%
PM (TTM) 10.48%
GM 40.65%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
The number of shares outstanding for DORM has been reduced compared to 1 year ago.
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.49 indicates that DORM is not in any danger for bankruptcy at the moment.
DORM has a better Altman-Z score (4.49) than 85.00% of its industry peers.
DORM has a debt to FCF ratio of 2.42. This is a good value and a sign of high solvency as DORM would need 2.42 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.42, DORM belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
A Debt/Equity ratio of 0.33 indicates that DORM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.33, DORM is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
Although DORM does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.42
Altman-Z 4.49
ROIC/WACC1.32
WACC9.54%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.62. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
DORM's Current ratio of 2.62 is amongst the best of the industry. DORM outperforms 82.50% of its industry peers.
DORM has a Quick Ratio of 1.22. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DORM (1.22) is better than 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.62
Quick Ratio 1.22
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.39% over the past year.
The Earnings Per Share has been growing by 21.83% on average over the past years. This is a very strong growth
DORM shows a small growth in Revenue. In the last year, the Revenue has grown by 6.03%.
Measured over the past years, DORM shows a quite strong growth in Revenue. The Revenue has been growing by 15.18% on average per year.
EPS 1Y (TTM)48.39%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%54.2%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%8.32%

3.2 Future

The Earnings Per Share is expected to grow by 10.00% on average over the next years. This is quite good.
DORM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.76% yearly.
EPS Next Y11.5%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.75%
Revenue Next 2Y4.76%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.80, which indicates a correct valuation of DORM.
DORM's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.30, DORM is valued a bit cheaper.
With a Price/Forward Earnings ratio of 14.36, DORM is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DORM is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.76. DORM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.8
Fwd PE 14.36
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM indicates a slightly more expensive valuation: DORM is more expensive than 68.75% of the companies listed in the same industry.
DORM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. DORM is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.85
EV/EBITDA 11.15
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DORM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)1.37
PEG (5Y)0.72
EPS Next 2Y10%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (7/8/2025, 8:20:11 PM)

Premarket: 124.04 0 (0%)

124.04

-0.85 (-0.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners85.28%
Inst Owner Change0%
Ins Owners10.81%
Ins Owner Change-3.15%
Market Cap3.78B
Analysts82
Price Target148.67 (19.86%)
Short Float %3.9%
Short Ratio5.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.89%
Min EPS beat(2)9.67%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)27.34%
Min EPS beat(4)9.67%
Max EPS beat(4)37.78%
EPS beat(8)6
Avg EPS beat(8)19.23%
EPS beat(12)6
Avg EPS beat(12)8.17%
EPS beat(16)8
Avg EPS beat(16)6.1%
Revenue beat(2)1
Avg Revenue beat(2)1.53%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)3.34%
Revenue beat(4)1
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)1
Avg Revenue beat(8)-1.83%
Revenue beat(12)3
Avg Revenue beat(12)-0.7%
Revenue beat(16)7
Avg Revenue beat(16)0.78%
PT rev (1m)0%
PT rev (3m)5.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.04%
EPS NY rev (1m)0%
EPS NY rev (3m)1.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.8
Fwd PE 14.36
P/S 1.85
P/FCF 19.85
P/OCF 16.43
P/B 2.83
P/tB 6.09
EV/EBITDA 11.15
EPS(TTM)7.85
EY6.33%
EPS(NY)8.64
Fwd EY6.97%
FCF(TTM)6.25
FCFY5.04%
OCF(TTM)7.55
OCFY6.09%
SpS67.13
BVpS43.83
TBVpS20.37
PEG (NY)1.37
PEG (5Y)0.72
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 16.05%
ROCE 16.75%
ROIC 12.64%
ROICexc 13.05%
ROICexgc 21.36%
OM 15.55%
PM (TTM) 10.48%
GM 40.65%
FCFM 9.31%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score8
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.42
Debt/EBITDA 1.17
Cap/Depr 69.94%
Cap/Sales 1.94%
Interest Coverage 9.68
Cash Conversion 61.38%
Profit Quality 88.81%
Current Ratio 2.62
Quick Ratio 1.22
Altman-Z 4.49
F-Score8
WACC9.54%
ROIC/WACC1.32
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)48.39%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%54.2%
EPS Next Y11.5%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.03%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%8.32%
Revenue Next Year4.75%
Revenue Next 2Y4.76%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.62%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year26.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5347.23%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y415.22%
OCF growth 3Y32.07%
OCF growth 5Y19.38%